Several Nrf2 activators have shown protective effects, such as tertbuthyl-hydroquinene, which was shown to be beneficial in cellular models of PD [173], in a rat model of HD [171] and in AβPP/PS1 AD model transgenic mice [172]. Here, NFE2L2 is linked to Parkinson disease.